Extended Data Fig. 5: Neutralization susceptibility of B.1.1.7 and B.1.351 variants to additional SARS-CoV-2 RBD-directed monoclonal antibodies. | Nature

Extended Data Fig. 5: Neutralization susceptibility of B.1.1.7 and B.1.351 variants to additional SARS-CoV-2 RBD-directed monoclonal antibodies.

From: Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Extended Data Fig. 5

a, Neutralization of B.1.1.7, B.1.351 and wild-type viruses by additional RBD-directed monoclonal antibodies. Data are mean ± s.e.m. of technical triplicates. b, Fold increase or decrease in IC50 of neutralizing monoclonal antibodies against B.1.1.7 and B.1.351, as well as mutant pseudoviruses, relative to the wild type. Red, resistance >3-fold; green, sensitization >3-fold.

Back to article page